Market Cap 941.71M
Revenue (ttm) 1.61B
Net Income (ttm) -6.94M
EPS (ttm) N/A
PE Ratio 5.20
Forward PE 5.61
Profit Margin -0.43%
Debt to Equity Ratio 1.73
Volume 695,490
Avg Vol 1,162,284
Day's Range N/A - N/A
Shares Out 77.89M
Stochastic %K 66%
Beta 1.20
Analysts Hold
Price Target $16.89

Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cran...

Industry: Medical Devices
Sector: Healthcare
Phone: 609 275 0500
Fax: 609 750 4277
Address:
1100 Campus Road, Princeton, United States
scoobydoo16
scoobydoo16 Nov. 12 at 11:04 PM
$IART Why the drop AH?
0 · Reply
lecorb
lecorb Nov. 11 at 11:31 PM
$IART The FDA has granted 510(k) clearance for the Integra LifeSciences' (IART) CUSA Clarity Ultrasonic Surgical Aspirator System for use in cardiac surgeries. This includes debridement of unwanted tissue in cardiac surgeries, as well as valve replacement and repair. The device was already in use for surgical procedures where fragmentation, emulsification and aspiration of soft and bone tissue is required, such as neurosurgery, plastic and reconstructive surgery, orthopedic surgery, thoracic surgery, laparoscopic surgery, gynecological surgery, and liver resection and transplant surgery.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 11 at 11:13 PM
1 · Reply
onlythebestcompanies
onlythebestcompanies Nov. 8 at 5:48 AM
$IART $20 soon
1 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 3:26 PM
Truist Securities has updated their rating for Integra Lifesciences ( $IART ) to Hold with a price target of 13.
0 · Reply
GlobalInsights
GlobalInsights Nov. 1 at 5:58 AM
$IART CMS final rule $127 per sq cm https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-medicare-physician-fee-schedule-final-rule-cms-1832-f
0 · Reply
onlythebestcompanies
onlythebestcompanies Oct. 30 at 11:24 PM
$IART $20 soon.
0 · Reply
prismmarketview
prismmarketview Oct. 30 at 2:10 PM
(Nasdaq: $IART) Integra LifeSciences beats Q3 EPS expectations ($0.54 vs. $0.43) as margins expand and neurosurgery sales climb 13%. Revenues rose 5.6% to $402M amid supply challenges. Full-year EPS raised to $2.X.24. https://prismmarketview.com/integra-lifesciences-delivers-strong-q3-profit-growth-despite-revenue-shortfall-raises-full-year-outlook/
1 · Reply
Estimize
Estimize Oct. 28 at 11:51 AM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Oct. 21 at 12:00 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on IART
Integra LifeSciences Still Recovering From Self-Inflicted Wounds

Sep 10, 2025, 3:05 PM EDT - 2 months ago

Integra LifeSciences Still Recovering From Self-Inflicted Wounds


Jan De Witte joins GHO Capital as Operating Partner

Feb 11, 2025, 4:30 AM EST - 9 months ago

Jan De Witte joins GHO Capital as Operating Partner

RMD


scoobydoo16
scoobydoo16 Nov. 12 at 11:04 PM
$IART Why the drop AH?
0 · Reply
lecorb
lecorb Nov. 11 at 11:31 PM
$IART The FDA has granted 510(k) clearance for the Integra LifeSciences' (IART) CUSA Clarity Ultrasonic Surgical Aspirator System for use in cardiac surgeries. This includes debridement of unwanted tissue in cardiac surgeries, as well as valve replacement and repair. The device was already in use for surgical procedures where fragmentation, emulsification and aspiration of soft and bone tissue is required, such as neurosurgery, plastic and reconstructive surgery, orthopedic surgery, thoracic surgery, laparoscopic surgery, gynecological surgery, and liver resection and transplant surgery.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 11 at 11:13 PM
1 · Reply
onlythebestcompanies
onlythebestcompanies Nov. 8 at 5:48 AM
$IART $20 soon
1 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 3:26 PM
Truist Securities has updated their rating for Integra Lifesciences ( $IART ) to Hold with a price target of 13.
0 · Reply
GlobalInsights
GlobalInsights Nov. 1 at 5:58 AM
$IART CMS final rule $127 per sq cm https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-medicare-physician-fee-schedule-final-rule-cms-1832-f
0 · Reply
onlythebestcompanies
onlythebestcompanies Oct. 30 at 11:24 PM
$IART $20 soon.
0 · Reply
prismmarketview
prismmarketview Oct. 30 at 2:10 PM
(Nasdaq: $IART) Integra LifeSciences beats Q3 EPS expectations ($0.54 vs. $0.43) as margins expand and neurosurgery sales climb 13%. Revenues rose 5.6% to $402M amid supply challenges. Full-year EPS raised to $2.X.24. https://prismmarketview.com/integra-lifesciences-delivers-strong-q3-profit-growth-despite-revenue-shortfall-raises-full-year-outlook/
1 · Reply
Estimize
Estimize Oct. 28 at 11:51 AM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Oct. 21 at 12:00 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Winning_calls
Winning_calls Oct. 20 at 2:37 AM
$IART pick me up @ $15.12
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 3:14 PM
Truist Securities has updated their rating for Integra Lifesciences ( $IART ) to Hold with a price target of 15.
0 · Reply
Estimize
Estimize Oct. 8 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Kaltycoon
Kaltycoon Sep. 24 at 5:06 PM
$CLPT $IART can we get some love at IART
0 · Reply
Estimize
Estimize Sep. 24 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
JessePhelps536
JessePhelps536 Sep. 22 at 8:13 AM
$IART Healthcare equipment consistency. Steady uptrend intact. Institutional demand steady. Low volatility.
0 · Reply
ZacksResearch
ZacksResearch Sep. 16 at 3:55 PM
Is $IART struggling or seizing opportunities? 🤔 🌍 Strong international growth and CSS segment prospects 📉 Macroeconomic challenges and liquidity concerns 📊 Stock down 12.1% in the past year with a Zacks Rank #3 Full analysis here 👉 https://www.zacks.com/stock/news/2752209/should-you-continue-to-hold-integra-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2752209-body-12646&ADID=SYND_STOCKTWITS_TWEET_2_2752209_BODY_12646
0 · Reply
ZacksResearch
ZacksResearch Sep. 16 at 2:55 PM
$IART — hold or fold? 🤔 The big question now is whether keeping Integra in your portfolio still makes sense, as the article weighs the case for investors. Full breakdown here 👉 https://www.zacks.com/stock/news/2752209/should-you-continue-to-hold-integra-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2752209-teaser-12616&ADID=SYND_STOCKTWITS_TWEET_2_2752209_TEASER_12616
0 · Reply
FillPhantom
FillPhantom Sep. 15 at 10:08 AM
$IART Resilient cash flows expected; monitor pricing power and competition
0 · Reply
HodlCommander
HodlCommander Sep. 12 at 5:46 PM
Integrating quantum sensors could shape the future of neurosurgery. $IART (Integra LifeSciences) gets a mention in AlphaBriefing’s article on quantum sensors and BCIs: https://www.alphabriefing.com/quantum-sensors-inside-living-cells-the-next-frontier-for-brain-computer-interfaces/
0 · Reply
Estimize
Estimize Sep. 10 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Aug. 27 at 12:09 PM
Wall St is expecting 0.44 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply